Sep 14, 2020 by Brian Orelli, PhDVaxart Gets FDA Sign-Off on Phase 1 Clinical Trial for Its Coronavirus VaccineThe clinical trial is scheduled to start this month.
Sep 14, 2020 by Brian Orelli, PhDAstraZeneca Resumes U.K. Clinical Trials of Its Coronavirus Vaccine After a Safety PauseThe studies were paused for less than a week.
Sep 13, 2020 by Brian Orelli, PhDMerck (Finally) Starts a Clinical Trial of its Coronavirus VaccineBetter late than never.
Sep 13, 2020 by Brian Orelli, PhDPfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical TrialThe expansion shouldn't affect the initial data readout.
Sep 13, 2020 by Brian Orelli, PhDModerna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical TrialWeek-over-week enrollment declined 47%.
Sep 11, 2020 by Brian Orelli, PhDSenate Considers Bill to Block International Distribution of Coronavirus VaccineCompanies could only distribute the vaccine internationally if domestic need is met.
Sep 9, 2020 by Brian Orelli, PhDPfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EUThe duo is in contract negotiations with the European Commission.
Sep 8, 2020 by Brian Orelli, PhDAstraZeneca Coronavirus Vaccine Clinical Trial PausedOne participant fell ill, but the connection to treatment with AZD122 is unclear.
Sep 5, 2020 by Brian Orelli, PhDModerna Reports 71% Enrollment in Coronavirus Vaccine TrialThe race to develop the first coronavirus vaccine continues.
Sep 4, 2020 by Brian Orelli, PhDModerna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureA quick approval would be nice, but the drugmakers are sticking to their scientific principals.
Sep 3, 2020 by Brian Orelli, PhDNovavax Publishes Coronavirus Vaccine Phase 1 Data in The New England Journal of MedicineThe details look as good as the initial report.
Sep 3, 2020 by Brian Orelli, PhDBetter Late Than Never: Sanofi and GlaxoSmithKline Start Coronavirus Vaccine Clinical Trial ProgramWith competitors already in phase 3 development, the European drugmakers are just now starting a phase 1/2 clinical trial.
Sep 1, 2020 by Brian Orelli, PhDAstraZeneca Boosts Manufacturing of Its Coronavirus Vaccine With a $66 Million-Plus DealOxfored Biomedica will help the pharma giant manufacture AZD1222.
Aug 31, 2020 by Brian Orelli, PhDFDA Willing to Authorize Coronavirus Vaccine Before Phase 3 Trials Are Complete, Agency Head SaysHowever, the ultimate decision will be based on the data the companies submit, he notes.
Aug 30, 2020 by Brian Orelli, PhDIf You'd Invested $5,000 In BioNTech's IPO, This Is How Much Money You'd Have NowInvestors who saw the pandemic coming made a killing.
Aug 28, 2020 by Brian Orelli, PhDGilead Gains Expanded FDA Authorization for COVID-19 Treatment RemdesivirThe drug can now be used by hospitalized patients with moderate COVID-19.
Aug 28, 2020 by Brian Orelli, PhDModerna in Talks to Sell 40 Million Coronavirus Vaccine Doses to JapanInvestors will want to keep an eye on what price the biotech can fetch for its vaccine.
Aug 27, 2020 by Brian Orelli, PhDHere's Why Quidel, Hologic, and Quest Diagnostics Shares Fell TodayRival Abbott is looking to become the dominant player in the coronavirus test arena.
Aug 26, 2020 by Brian Orelli, PhDAbbott Receives FDA Authorization for a $5 App-Enabled 15-Minute COVID-19 TestThe cheap, rapid test could help get people back to work.
Aug 26, 2020 by Brian Orelli, PhDSorrento Therapeutics Opened Up 11.7% After CEO Slams Short SellersThe biotech's valuation could be important in the short term.
